Showing 1 - 15 results of 15 for search 'Michael S. Hughes', query time: 0.03s
Refine Results
-
1
-
2
-
3
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infecte... by Amita Gupta, Michael D Hughes, Anthony J Garcia-Prats, Katherine McIntire, Anneke C Hesseling
Published 2019-08-01Get full text
Article -
4
-
5
-
6
Changes in peripheral blood mononuclear cell electrical properties in response to viral exposure and vaccination by Krista S. P. Clarke, Alexander T. Stewart, Emma L. Sinclair, Rebecca Lewis, Fatima H. Labeed, Deborah K. Dunn-Walters, Michael Pycraft Hughes
Published 2025-07-01Get full text
Article -
7
-
8
GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism by Shirong Li, Josefine Krüger, Guifen Liu, Huihui Ma, Michael S. Hughes, Rajshekhar Chakraborty, Divaya Bhutani, Markus Y. Mapara, Christophe Marcireau, Suzanne Lentzsch, Jing Fu
Published 2025-08-01Get full text
Article -
9
Statistical methodologies for evaluation of the rate of persistence of Ebola virus in semen of male survivors in Sierra Leone. by Ndema Habib, Michael D Hughes, Nathalie Broutet, Anna Thorson, Philippe Gaillard, Sihem Landoulsi, Suzanne L R McDonald, Pierre Formenty, Sierra Leone Ebola Virus Persistence Study Group
Published 2022-01-01Get full text
Article -
10
-
11
Subchronic Toxicities of Four Per- and Polyfluoroalkyl Substances (PFASs) by Oral Exposure in Sprague–Dawley Rats by Elaina M. Kenyon, Michael J. Devito, Grace Patlewicz, Linda D. Adams, Russell S. Thomas, Jeffrey L. Ambroso, Xi Yang, James C. Blake, Bindu G. Upadhyay, Johnathan Furr, Michael F. Hughes
Published 2025-06-01Get full text
Article -
12
Immunotoxicity of Four Per- and Polyfluoroalkyl Substances Following 28-Day Oral Repeat Dosing in Rats Assessed by the Anti-Sheep Red Blood Cell IgM Response by Michael F. Hughes, Michael J. DeVito, Grace Patlewicz, Russell S. Thomas, Linda D. Adams, Jeffrey L. Ambroso, Xi Yang, Bindu G. Upadhyay, Stefanie C. M. Burleson, Elaina M. Kenyon
Published 2025-06-01Get full text
Article -
13
PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin by Blake Gilks, Martin Köbel, Diana Canals Hernaez, Michael R Hughes, Pamela Dean, Peter Bergqvist, Ismael Samudio, Ola Blixt, Katharina Wiedemeyer, Yicong Li, Chris Bond, Eric Cruz, Calvin D Roskelley, Kelly M McNagny
Published 2020-10-01Get full text
Article -
14
Intermittent estuaries deserve global attention as vulnerable and vital ecosystems by Danial Khojasteh, Shivanesh Rao, Sarah McSweeney, Raimundo Ibaceta, Robert J. Nicholls, Jon French, William Glamore, John L. Largier, Janine Adams, Michael G. Hughes, Michael Barry, Hannah E. Power, Jiabi Du, Tobias A. Tucker, Rodrigo Cienfuegos, Patricio A. Catalan, David Hanslow
Published 2025-06-01Get full text
Article -
15
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies by Rachel A. Bender Ignacio, Kara W. Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan, Mark J. Giganti, Justin Ritz, Michael Gibbs, Hervé Tchouakam Kouekam, Mark T. Esser, Eric S. Daar, Manish Choudhary, Rinki Deo, Courtney V. Fletcher, Jonathan Z. Li, Michael D. Hughes, Davey Smith, David Alain Wohl
Published 2025-03-01Get full text
Article